PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
4 hedge funds and large institutions have $4.78M invested in PureTech Health in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.21% more ownership
Funds ownership: 0% → 0.21% (+0.21%)
Top Buyers
| 1 |
BHIA
Birch Hill Investment Advisors
Boston,
Massachusetts
|
+$13.4M |
| 2 |
CG
Colony Group
Boston,
Massachusetts
|
+$11.7M |
| 3 |
AIC
AWM Investment Company
New York
|
+$1.33M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.99K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
1
AWM Investment Company
New York
| $1.67M | +$1.33M | +30,000 | New |
|
|
BHIA
2
Birch Hill Investment Advisors
Boston,
Massachusetts
| $1.66M | +$13.4M | +302,000 | New |
|
|
CG
3
Colony Group
Boston,
Massachusetts
| $1.44M | +$11.7M | +262,600 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $12K | +$9.99K | +225 | New |
|
PRTC Hedge Fund Activity: Q4 2020 in Review
4 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q4 2020, worth a combined $4.78M.
Buyers outnumbered sellers: 4 funds opened new PRTC positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Birch Hill Investment Advisors, opening a new position worth an estimated $13.4M.
- 4 institutional investors held PureTech Health (PRTC) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $4.78M of PureTech Health stock for Q4 2020.
- 4 funds opened new PureTech Health positions in Q4 2020 and 0 closed out, a net change of +4 holders.
- The largest PureTech Health buyer in Q4 2020 was Birch Hill Investment Advisors, an estimated $13.4M added.
Based on aggregated 13F filings for Q4 2020.